Synergistic Targeting of AML Stem/Progenitor Cells With IAP Antagonist Birinapant and Demethylating Agents

BACKGROUND: Acute myeloid leukemia (AML) therapy has limited long-term efficacy because patients frequently develop disease relapse because of the inability of standard chemotherapeutic agents to target AML stem/progenitor cells. Here, we identify deregulated apoptotic components in AML stem/progeni...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Carter, Bing Z., Mak, Po Yee, Mak, Duncan H., Shi, Yuexi, Qiu, Yihua, Bogenberger, James M., Mu, Hong, Tibes, Raoul, Yao, Hui, Coombes, Kevin R., Jacamo, Rodrigo O., McQueen, Teresa, Kornblau, Steven M., Andreeff, Michael
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952202/
https://ncbi.nlm.nih.gov/pubmed/24526787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt440
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items